Skip to main content
Year archive

Bio Solution Co.,Ltd. — 2024 filings

All 22 regulatory filings released by Bio Solution Co.,Ltd. (086820) in 2024, sourced directly from the official regulator.

22 Filings
2024 Period
2024 filings (22)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2024-12-13 Korean
분기보고서 (2024.09)
Interim / Quarterly Report 9M 2024
2024-11-14 Korean
대표이사변경
Board/Management Information
2024-09-30 Korean
소송등의판결ㆍ결정
Legal Proceedings Report
2024-09-06 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2024-08-22 Korean
반기보고서 (2024.06)
Interim / Quarterly Report H1 2024
2024-08-14 Korean
본점소재지변경
Regulatory Filings
2024-07-09 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings
2024-06-28 Korean
투자판단관련주요경영사항(임상시험계획자진취하등) (펠렛형 동종 연골세포치료제카티로이드의 제1/2상 임상시험계획승인 신청IND 자진취하)
Legal Proceedings Report
2024-06-13 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Q1 2024
2024-05-16 Korean
투자판단관련주요경영사항(임상시험결과) (카티라이프(바솔자가연골유래연골세포)의 임상 3상 시험 1차 유효성 평가(48주) 결과)
Regulatory Filings
2024-04-15 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2024-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2024-03-28 Korean
주요사항보고서(영업정지)
Legal Proceedings Report
2024-03-25 Korean
감사보고서제출
Audit Report / Information FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Audit Report / Information FY 2023
2024-03-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2024-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2024-03-08 Korean
주주총회소집결의
AGM Information
2024-03-07 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2023
2024-02-14 Korean
타법인주식및출자증권취득결정(자율공시)
M&A Activity
2024-02-05 Korean
기업설명회(IR)개최
Report Publication Announcement
2024-01-03 Korean